- Home
- IPHA vs AVD Comparison
IPHA vs AVD Comparison
Compare IPHA & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- AVD
- Stock Information
- Founded
- IPHA 1999
- AVD 1969
- Country
- IPHA France
- AVD United States
- Employees
- IPHA N/A
- AVD N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- AVD Agricultural Chemicals
- Sector
- IPHA Health Care
- AVD Industrials
- Exchange
- IPHA Nasdaq
- AVD Nasdaq
- Market Cap
- IPHA 171.6M
- AVD 171.3M
- IPO Year
- IPHA 2019
- AVD N/A
- Fundamental
- Price
- IPHA $2.25
- AVD $5.88
- Analyst Decision
- IPHA Strong Buy
- AVD Strong Buy
- Analyst Count
- IPHA 1
- AVD 3
- Target Price
- IPHA $11.50
- AVD $16.67
- AVG Volume (30 Days)
- IPHA 6.4K
- AVD 258.4K
- Earning Date
- IPHA 09-12-2024
- AVD 11-06-2024
- Dividend Yield
- IPHA N/A
- AVD 2.01%
- EPS Growth
- IPHA N/A
- AVD N/A
- EPS
- IPHA N/A
- AVD N/A
- Revenue
- IPHA $36,202,722.00
- AVD $585,049,000.00
- Revenue This Year
- IPHA N/A
- AVD N/A
- Revenue Next Year
- IPHA $105.84
- AVD $4.69
- P/E Ratio
- IPHA N/A
- AVD N/A
- Revenue Growth
- IPHA N/A
- AVD 2.73
- 52 Week Low
- IPHA $1.81
- AVD $4.95
- 52 Week High
- IPHA $3.15
- AVD $14.28
- Technical
- Relative Strength Index (RSI)
- IPHA 49.51
- AVD 40.97
- Support Level
- IPHA $2.22
- AVD $5.86
- Resistance Level
- IPHA $2.29
- AVD $6.58
- Average True Range (ATR)
- IPHA 0.13
- AVD 0.25
- MACD
- IPHA -0.01
- AVD 0.10
- Stochastic Oscillator
- IPHA 48.09
- AVD 27.63
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.